JNJ បានទិញភាគហ៊ុន Biotech MeiraGtx ។ វាបានលក់ Procept BioRobotics ។



ចនសុននិងចនសុន


recently increased an investment in an embattled biotech stock, and slashed a position in a maker of surgical robotics that rocketed last year.

Johnson & Johnson (ticker: JNJ) more than doubled an investment in


MeiraGTx


Holdings (MGTX), and more than halved a stake in


Procept BioRobotics


(PRCT) in the fourth quarter. J&J disclosed the investment changes, among others, in ទម្រង់​ដែល​វា​បាន​ដាក់ ជាមួយគណៈកម្មការមូលបត្រ។

Source: https://www.barrons.com/articles/jnj-biotech-stock-meiragtx-procept-2c46ad81?siteid=yhoof2&yptr=yahoo